Document is current
Any future updates will be listed below
-
Authors
Higgins, Bethany E. https://orcid.org/0000-0002-4530-6156
Montesano, Giovanni https://orcid.org/0000-0002-9148-2804
Binns, Alison M. https://orcid.org/0000-0001-8621-498X
Crabb, David P. https://orcid.org/0000-0001-8754-3902
- License Information
-
More Information
Article History
Received: 11 November 2020
Accepted: 1 March 2021
First Online: 15 April 2021
Competing interests
: GM, DPC and AMB received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant 116076 (MACUSTAR). This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation program and European Federation of Pharmaceutical Industries and Associations (EFPIA). The communication reflects the authors’ view and that neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein. GM is a consultant for CenterVue and DPC is a consultant for CenterVue and Apellis, has received speaker’s fees from Santen, Allergan and Bayer, and has received compensation as a member of the scientific advisory board of Roche. These affiliations do not directly impact the work in this manuscript. Remaining author BEH declares that they have no conflict of interest.
